Stockscreener 앱 받기
52.68
1.62%
-0.87
시간 외 거래:
52.64
-0.04
-0.08%
전일 마감가:
$53.55
열려 있는:
$54.19
하루 거래량:
14.80M
Relative Volume:
0.92
시가총액:
$78.30B
수익:
$20.62B
순이익/손실:
$3.56B
주가수익비율:
22.09
EPS:
2.3847
순현금흐름:
$3.48B
1주 성능:
-2.32%
1개월 성능:
-18.46%
6개월 성능:
-48.70%
1년 성능:
-49.76%
1일 변동 폭
$52.52
$54.40
1주일 범위
$52.52
$54.48
52주 변동 폭
$52.52
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
52.68 | 79.59B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
84.47 | 147.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
306.76 | 117.12B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
76.15 | 98.82B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
81.38 | 46.84B | 6.30B | 1.07B | 1.09B | 1.8406 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific plunges 43% YTD amid weak outlook but shows potential for recovery with new Buy rating. - Pluang
Boston Scientific Corp. stock (US10117L1017): recent earnings, device pipeline and outlook - AD HOC NEWS
Why this $23-billion money manager is buying Caterpillar and selling Boston Scientific - The Globe and Mail
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Here's How Boston Scientific Is Expanding Its Global Growth - Yahoo Finance
Jim Cramer on Boston Scientific: “I Think You Gotta Hold It” - Insider Monkey
Boston Scientific (BSX) Fell Amid Concerns Over Growth Durability - Yahoo Finance
NWK Group, Inc.'s Boston Scientific Corp(BSX) Holding History - GuruFocus
Strategic Advisers Fidelity Alternatives Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Is Boston Scientific (BSX) Quietly Recasting Its Ownership Structure To Sharpen Its Investment Story? - Yahoo Finance
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Scientific (BSX) Valuation After Morningstar Downgrade And Significantly Undervalued Rating - Yahoo Finance
Boston Scientific Corp. stock (US10117L1017): Hits 52-week low at $53.10 - AD HOC NEWS
Boston Scientific stock hits 52-week low at $53.10 By Investing.com - Investing.com Nigeria
Boston Scientific stock hits 52-week low at $53.10 - Investing.com
Boston Scientific Corp. stock (US10117L1017): FMR LLC cuts major stake in Q1 2026 - AD HOC NEWS
Boston Scientific Insiders Sold US$1.2m Of Shares Suggesting Hesitancy - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...' - Benzinga
Boston Scientific faces share pressure but holds strong in key medtech areas with growth potential. - Pluang
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific (NYSE: BSX) director Ellen M. Zane receives $215,000 stock grant - Stock Titan
Boston Scientific (NYSE: BSX) director receives 3,800-share restricted stock grant - Stock Titan
Boston Scientific (NYSE: BSX) director receives major equity awards - Stock Titan
Boston Scientific (NYSE: BSX) director receives deferred stock unit awards as equity pay - Stock Titan
Boston Scientific (NYSE: BSX) director granted deferred stock units - Stock Titan
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
Boston Scientific (BSX) director receives $215,000 restricted stock award - Stock Titan
BSX Stock Quote Price and Forecast - CNN
9 New 5-Star Stocks This Week - Morningstar
Boston Scientific Corp. stock (US10117L1017): Shares open at $53.89 amid acquisition scrutiny - AD HOC NEWS
Boston Scientific Corp. stock (US10117L1017): Shares slide amid valuation debate - AD HOC NEWS
Boston Scientific Corp. stock (US10117L1017): Shares hit 52-week low after earnings beat and guidanc - AD HOC NEWS
Boston Scientific Corp (BSX) Stock Down 4.7% -- Now Undervalued? GF Score: 84/100 - GuruFocus
Endeavor plans to redevelop 24-acre Boston Scientific campus in Minnetonka - The Business Journals
Boston Scientific’s pacemaker recall is most serious type: FDA - Modern Healthcare News
Fund Update: 191,081 BOSTON SCIENTIFIC (BSX) shares added to Glenview Trust Co portfolio - Quiver Quantitative
Boston Scientific principal’s advice: ‘Build the doors you want to walk through’ - The Business Journals
Boston Scientific Corp. Stock (US10117L1017): Hits 52-Week Low Amid Analyst Downgrades and Guidance - AD HOC NEWS
Boston Scientific Announces Software Upgrade for Pacemakers Amid Recall - GuruFocus
US FDA issues recall of Boston Scientific heart devices - Reuters
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Penumbra shareholders approve merger with Boston Scientific - Investing.com
Fund Update: 543,460 BOSTON SCIENTIFIC (BSX) shares added to Mawer Investment Management Ltd. portfolio - Quiver Quantitative
FMR LLC updates Boston Scientific holding (NYSE: BSX) — 75.8M shares - Stock Titan
Do Boston Scientific's (NYSE:BSX) Earnings Warrant Your Attention? - Yahoo Finance
Boston Scientific Corporation Restated Certificate of Incorporation: Key Provisions, Director Rights, and Shareholder Protections - Minichart
Boston Scientific shareholders approve charter amendments and board elections By Investing.com - Investing.com Canada
Boston Scientific shareholders approve charter amendments and board elections - Investing.com
Boston Scientific (NYSE: BSX) investors approve charter changes and board slate - Stock Titan
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
보스턴사이언티픽 주식 (BSX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Butcher Arthur C | EVP& Grp Pres, MedSurg & APAC |
May 02 '26 |
Option Exercise |
0.00 |
2,102 |
0 |
57,894 |
| Woodworth Emily | SVP, Global Controller and CAO |
Mar 01 '26 |
Option Exercise |
0.00 |
838 |
0 |
3,231 |
| O'Connor Padraig Andrew | EVP, Global Operations |
Feb 16 '26 |
Option Exercise |
0.00 |
905 |
0 |
6,433 |
| O'Connor Padraig Andrew | EVP, Global Operations |
Feb 14 '26 |
Option Exercise |
0.00 |
1,190 |
0 |
5,977 |
| O'Connor Padraig Andrew | EVP, Global Operations |
Feb 13 '26 |
Option Exercise |
0.00 |
500 |
0 |
4,986 |
| Woodworth Emily | SVP, Global Controller and CAO |
Feb 16 '26 |
Option Exercise |
0.00 |
637 |
0 |
2,676 |
| Woodworth Emily | SVP, Global Controller and CAO |
Feb 14 '26 |
Option Exercise |
0.00 |
661 |
0 |
2,335 |
| Woodworth Emily | SVP, Global Controller and CAO |
Feb 13 '26 |
Option Exercise |
0.00 |
1,413 |
0 |
2,364 |
| Monson Jonathan | EVP and CFO |
Feb 16 '26 |
Option Exercise |
0.00 |
990 |
0 |
38,426 |
| Monson Jonathan | EVP and CFO |
Feb 14 '26 |
Option Exercise |
0.00 |
1,058 |
0 |
37,906 |
1.07%
0.05%
자본화:
|
볼륨(24시간):